SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Daniel A. Galvão, Nigel Spry, James Denham, Dennis R. Taaffe, Prue Cormie, David Joseph, David S. Lamb, Suzanne K. Chambers, Robert U. Newton, A Multicentre Year-long Randomised Controlled Trial of Exercise Training Targeting Physical Functioning in Men with Prostate Cancer Previously Treated with Androgen Suppression and Radiation from TROG 03.04 RADAR, European Urology, 2014, 65, 5, 856

    CrossRef

  2. 2
    Prue Cormie, Daniel A. Galvão, Nigel Spry, David Joseph, Raphael Chee, Dennis R. Taaffe, Suzanne K. Chambers, Robert U. Newton, Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial, BJU International, 2014, 114, 3
  3. You have free access to this content3
    David Chang, David J Joseph, Martin A Ebert, Daniel A Galvão, Dennis R Taaffe, James W Denham, Robert U Newton, Nigel A Spry, Effect of androgen deprivation therapy on muscle attenuation in men with prostate cancer, Journal of Medical Imaging and Radiation Oncology, 2014, 58, 2
  4. 4
    Danielle Girard, Frank E. Marino, Jack Cannon, Evidence for reduced neuromuscular function in men with a history of androgen deprivation therapy for prostate cancer, Clinical Physiology and Functional Imaging, 2014, 34, 3
  5. 5
    L.M. Buffart, D.A. Galvão, J. Brug, M.J.M. Chinapaw, R.U. Newton, Evidence-based physical activity guidelines for cancer survivors: Current guidelines, knowledge gaps and future research directions, Cancer Treatment Reviews, 2014, 40, 2, 327

    CrossRef

  6. 6
    Prue Cormie, Daniel A. Galvão, Nigel Spry, David Joseph, Dennis R. Taaffe, Robert U. Newton, Functional benefits are sustained after a program of supervised resistance exercise in cancer patients with bone metastases: longitudinal results of a pilot study, Supportive Care in Cancer, 2014, 22, 6, 1537

    CrossRef

  7. 7
    Prue Cormie, Suzanne K Chambers, Robert U Newton, Robert A Gardiner, Nigel Spry, Dennis R Taaffe, David Joseph, M Hamid, Peter Chong, David Hughes, Kyra Hamilton, Daniel A Galvão, Improving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies, BMC Cancer, 2014, 14, 1, 199

    CrossRef

  8. 8
    Laurien M. Buffart, Daniel A. Galvão, Mai J. Chinapaw, Johannes Brug, Dennis R. Taaffe, Nigel Spry, David Joseph, Robert U. Newton, Mediators of the resistance and aerobic exercise intervention effect on physical and general health in men undergoing androgen deprivation therapy for prostate cancer, Cancer, 2014, 120, 2
  9. 9
    Nadine Beydoun, Joseph A. Bucci, Yaw S. Chin, Nigel Spry, Robert Newton, Daniel A. Galvão, Prospective study of exercise intervention in prostate cancer patients on androgen deprivation therapy, Journal of Medical Imaging and Radiation Oncology, 2014, 58, 3
  10. 10
    K. Hamilton, S. K. Chambers, M. Legg, J. L. Oliffe, P. Cormie, Sexuality and exercise in men undergoing androgen deprivation therapy for prostate cancer, Supportive Care in Cancer, 2014,

    CrossRef

  11. 11
    KERRI M. WINTERS-STONE, JESSICA C. DOBEK, JILL A. BENNETT, GIANNI F. MADDALOZZO, CHRISTOPHER W. RYAN, TOMASZ M. BEER, Skeletal Response to Resistance and Impact Training in Prostate Cancer Survivors, Medicine & Science in Sports & Exercise, 2014, 46, 8, 1482

    CrossRef

  12. 12
    Robert U. Newton, Daniel A. Galvão, Exercise medicine for prostate cancer, European Review of Aging and Physical Activity, 2013, 10, 1, 41

    CrossRef

  13. 13
    N A Spry, D R Taaffe, P J England, J S Judge, D A Stephens, C Peddle-McIntyre, M K Baker, R U Newton, D A Galvão, Long-term effects of intermittent androgen suppression therapy on lean and fat mass: a 33-month prospective study, Prostate Cancer and Prostatic Diseases, 2013, 16, 1, 67

    CrossRef

  14. 14
    Chiung-Kuei Huang, Kuo-Pao Lai, Jie Luo, Meng-Yin Tsai, Hong-Yo Kang, Yuhchyau Chen, Soo Ok Lee, Chawnshang Chang, Loss of androgen receptor promotes adipogenesis but suppresses osteogenesis in bone marrow stromal cells, Stem Cell Research, 2013, 11, 2, 938

    CrossRef

  15. 15
    Kelly Chipperfield, Jane Fletcher, Jeremy Millar, Joanne Brooker, Robin Smith, Mark Frydenberg, Sue Burney, Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy, Psycho-Oncology, 2013, 22, 10
  16. 16
    P Cormie, R U Newton, N Spry, D Joseph, D R Taaffe, D A Galvão, Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases, Prostate Cancer and Prostatic Disease, 2013, 16, 4, 328

    CrossRef

  17. 17
    E. D. Hanson, A. K. Sheaff, S. Sood, L. Ma, J. D. Francis, A. P. Goldberg, B. F. Hurley, Strength Training Induces Muscle Hypertrophy and Functional Gains in Black Prostate Cancer Patients Despite Androgen Deprivation Therapy, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2013, 68, 4, 490

    CrossRef

  18. 18
    J.-E. Terrier, N. Mottet, Syndrome métabolique et insulinorésistance chez les patients atteints de cancer de la prostate traités par suppression androgénique hormonale, Progrès en Urologie, 2013, 23, 2, 88

    CrossRef

  19. 19
    K A Bolam, D A Galvão, N Spry, R U Newton, D R Taaffe, AST-induced bone loss in men with prostate cancer: exercise as a potential countermeasure, Prostate Cancer and Prostatic Diseases, 2012, 15, 4, 329

    CrossRef

  20. 20
    Justin W.L. Keogh, Roderick D. MacLeod, Body Composition, Physical Fitness, Functional Performance, Quality of Life, and Fatigue Benefits of Exercise for Prostate Cancer Patients: A Systematic Review, Journal of Pain and Symptom Management, 2012, 43, 1, 96

    CrossRef

  21. 21
    Robert U Newton, Dennis R Taaffe, Nigel Spry, Prue Cormie, Suzanne K Chambers, Robert A Gardiner, David HK Shum, David Joseph, Daniel A Galvão, Can exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation?, BMC Cancer, 2012, 12, 1, 432

    CrossRef

  22. 22
    Susan G. Lakoski, Neil D. Eves, Pamela S. Douglas, Lee W. Jones, Exercise rehabilitation in patients with cancer, Nature Reviews Clinical Oncology, 2012, 9, 5, 288

    CrossRef

  23. 23
    Narhari Timilshina, Henriette Breunis, Shabbir M.H. Alibhai, Impact of Androgen Deprivation Therapy on Weight Gain Differs by Age in Men with Nonmetastatic Prostate Cancer, The Journal of Urology, 2012, 188, 6, 2183

    CrossRef

  24. 24
    Thomas W Storer, Renee Miciek, Thomas G Travison, Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy, Asian Journal of Andrology, 2012, 14, 2, 204

    CrossRef

  25. 25
    Howard S. Kim, Daniel M. Moreira, Matthew R. Smith, Joseph C. Presti, William J. Aronson, Martha K. Terris, Christopher J. Kane, Christopher L. Amling, Stephen J. Freedland, A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database, BJU International, 2011, 107, 6
  26. 26
    Daniel A. Galvão, Dennis R. Taaffe, Nigel Spry, David Joseph, Robert U. Newton, Acute Versus Chronic Exposure to Androgen Suppression for Prostate Cancer: Impact on the Exercise Response, The Journal of Urology, 2011, 186, 4, 1291

    CrossRef

  27. 27
    Kristene Myklak, Shandra Wilson, An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer, Prostate Cancer, 2011, 2011, 1

    CrossRef

  28. 28
    Jean-Baptiste Lattouf, Hicham Fadlallah, Fred Saad, Androgen Deprivation and Bone, Current Osteoporosis Reports, 2011, 9, 1, 20

    CrossRef

  29. 29
    Yves Rolland, Graziano Onder, John E. Morley, Sophie Gillette-Guyonet, Gabor Abellan van Kan, Bruno Vellas, Current and Future Pharmacologic Treatment of Sarcopenia, Clinics in Geriatric Medicine, 2011, 27, 3, 423

    CrossRef

  30. 30
    Daniel A Galvão, Dennis R Taaffe, Prue Cormie, Nigel Spry, Suzanne K Chambers, Carolyn Peddle-McIntyre, Michael Baker, James Denham, David Joseph, Geoff Groom, Robert U Newton, Efficacy and safety of a modular multi-modal exercise program in prostate cancer patients with bone metastases: a randomized controlled trial, BMC Cancer, 2011, 11, 1, 517

    CrossRef

  31. 31
    Erik D. Hanson, Ben F. Hurley, Intervening on the Side Effects of Hormone-Dependent Cancer Treatment: The Role of Strength Training, Journal of Aging Research, 2011, 2011, 1

    CrossRef

  32. 32
    Bhavin R. Shastri, Subhashini Yaturu, Metabolic Complications and Increased Cardiovascular Risks as a Result of Androgen Deprivation Therapy in Men with Prostate Cancer, Prostate Cancer, 2011, 2011, 1

    CrossRef

  33. 33
    Mark A. Moyad, Mack Roach, Promoting Wellness for Patients on Androgen Deprivation Therapy: Why Using Numerous Drugs for Drug Side Effects Should Not Be First-Line Treatment, Urologic Clinics of North America, 2011, 38, 3, 303

    CrossRef

  34. 34
    Aksam A. Yassin, Farid Saad, Ahmad Haider, Louis Gooren, The role of the urologist in the prevention and early detection of cardiovascular disease, Arab Journal of Urology, 2011, 9, 1, 57

    CrossRef

  35. 35
    General Practice, 2011,

    CrossRef

  36. 36
    Howard S Kim, Stephen J Freedland, Androgen deprivation therapy in prostate cancer: anticipated side-effects and their management, Current Opinion in Supportive and Palliative Care, 2010, 4, 3, 147

    CrossRef

  37. 37
    Farhana Haseen, Liam J. Murray, Chris R. Cardwell, Joe M. O’Sullivan, Marie M. Cantwell, The effect of androgen deprivation therapy on body composition in men with prostate cancer: Systematic review and meta-analysis, Journal of Cancer Survivorship, 2010, 4, 2, 128

    CrossRef

  38. 38
    D A Galvão, D R Taaffe, N Spry, D Joseph, R U Newton, Cardiovascular and metabolic complications during androgen deprivation: exercise as a potential countermeasure, Prostate Cancer and Prostatic Diseases, 2009, 12, 3, 233

    CrossRef

  39. 39
    Pamela A. Hansen, Christopher B. Dechet, Christina A. Porucznik, Paul C. LaStayo, Comparing Eccentric Resistance Exercise in Prostate Cancer Survivors On and Off Hormone Therapy: A Pilot Study, PM&R, 2009, 1, 11, 1019

    CrossRef

  40. 40
    T Koreckij, H Nguyen, L G Brown, E Y Yu, R L Vessella, E Corey, Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis, British Journal of Cancer, 2009, 101, 2, 263

    CrossRef

  41. 41
    Nigel A. Spry, Daniel A. Galvão, Robert Davies, Shane La Bianca, David Joseph, Andrew Davidson, Richard Prince, Long-term effects of intermittent androgen suppression on testosterone recovery and bone mineral density: results of a 33-month observational study, BJU International, 2009, 104, 6
  42. 42
    Marina Mourtzakis, Megan Bedbrook, Muscle atrophy in cancer: a role for nutrition and exercise, Applied Physiology, Nutrition, and Metabolism, 2009, 34, 5, 950

    CrossRef

  43. 43
    D A Galvão, D R Taaffe, N Spry, D Joseph, D Turner, R U Newton, Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation, Prostate Cancer and Prostatic Diseases, 2009, 12, 2, 198

    CrossRef

  44. 44
    Corrigenda, BJU International, 2008, 102, 3
  45. 45
    Liam Bourke, Dianna Smith, Liz Steed, Richard Hooper, James Catto, Peter C Albertsen, Bertrand Tombal, Heather A Payne, Derek J Rosario, Exercise interventions for men with prostate cancer, The Cochrane Library,
  46. 46
    Miriam B. Rodin, Maintaining Functional Status,